Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0

Clinical trial NCT01621217 · COMPLETED

Trial details

NCT number: NCT01621217
Sponsor: Lund University Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Cancer in the Anal Region

Start date: 2012-06-01
Primary completion: 2020-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.